Novel Trial Endpoints: Opportunities and Challenges for New Surrogate Endpoints

January 15, 2018 — January 16, 2018

Manchester, United Kingdom

Novel clinical trial endpoints: Opportunities and challenges for new surrogate endpoints. Buyse M. Invited lecture at the UK Interdisciplinary Breast Cancer Symposium, Manchester, UK, January 15-16, 2018.

This two day conference will bring together the brightest minds in breast cancer management and research.  This meeting has the unambiguous aim of being the UK’s premier breast cancer conference.  Treatment of breast cancer has for many years been dependent on the interaction of professionals from many disciplines.  Research into improving our understanding of this complex disease and prospects for improving its prevention and treatment also require interdisciplinary collaboration to make meaningful advances.

Powered by Atypic ®

IDDI